VFA
IMGN

Valeo Financial Advisors’s Immunogen Inc IMGN Stock Holding History

Valeo Financial Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-120
Closed -$1K – 1960
2021
Q1 		$1K Buy
+120
New +$980 ﹤0.01% 1971
2019
Q1 		– Sell
-48
Closed – – 1654
2018
Q4 		$0 Hold
48
– – ﹤0.01% 1776
2018
Q3 		$0 Hold
48
– – ﹤0.01% 1888
2018
Q2 		$0 Sell
48
-750
-94% -$7.91K ﹤0.01% 1785
2018
Q1 		$8K Buy
+798
New +$7.88K ﹤0.01% 1005

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Valeo Financial Advisors's IMGN Position: Q2 2021 in Review

Valeo Financial Advisors sold out of Immunogen Inc (IMGN) in Q2 2021, closing a stake of 120 shares — an estimated $1K sold.

Valeo Financial Advisors first reported a position in IMGN in Q1 2018 and held it in 5 quarters. The position peaked at $8K in Q1 2018. 214 funds tracked by Wall St. Rank hold IMGN as of Q2 2021.

  • Valeo Financial Advisors reported no remaining Immunogen Inc position as of Q2 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 120 Immunogen Inc shares in Q2 2021, an estimated $1K.
  • Valeo Financial Advisors first reported a position in Immunogen Inc in Q1 2018 and held it in 5 quarters.
  • Valeo Financial Advisors's Immunogen Inc position peaked at $8K in Q1 2018.
  • 214 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.